-
Je něco špatně v tomto záznamu ?
Community-Wide Experimental Evaluation of the PROSS Stability-Design Method
Y. Peleg, R. Vincentelli, BM. Collins, KE. Chen, EK. Livingstone, S. Weeratunga, N. Leneva, Q. Guo, K. Remans, K. Perez, GEK. Bjerga, Ø. Larsen, O. Vaněk, O. Skořepa, S. Jacquemin, A. Poterszman, S. Kjær, E. Christodoulou, S. Albeck, O. Dym, E....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
815379
European Research Council - International
FC001999
Cancer Research UK - United Kingdom
FC001999
Medical Research Council - United Kingdom
Wellcome Trust - United Kingdom
- MeSH
- algoritmy * MeSH
- dánio pruhované MeSH
- Escherichia coli metabolismus MeSH
- HEK293 buňky MeSH
- lidé MeSH
- molekulární modely MeSH
- proteiny chemie metabolismus MeSH
- rozpustnost MeSH
- rychlé screeningové testy MeSH
- stabilita proteinů * MeSH
- teplota MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Recent years have seen a dramatic improvement in protein-design methodology. Nevertheless, most methods demand expert intervention, limiting their widespread adoption. By contrast, the PROSS algorithm for improving protein stability and heterologous expression levels has been successfully applied to a range of challenging enzymes and binding proteins. Here, we benchmark the application of PROSS as a stand-alone tool for protein scientists with no or limited experience in modeling. Twelve laboratories from the Protein Production and Purification Partnership in Europe (P4EU) challenged the PROSS algorithm with 14 unrelated protein targets without support from the PROSS developers. For each target, up to six designs were evaluated for expression levels and in some cases, for thermal stability and activity. In nine targets, designs exhibited increased heterologous expression levels either in prokaryotic and/or eukaryotic expression systems under experimental conditions that were tailored for each target protein. Furthermore, we observed increased thermal stability in nine of ten tested targets. In two prime examples, the human Stem Cell Factor (hSCF) and human Cadherin-Like Domain (CLD12) from the RET receptor, the wild type proteins were not expressible as soluble proteins in E. coli, yet the PROSS designs exhibited high expression levels in E. coli and HEK293 cells, respectively, and improved thermal stability. We conclude that PROSS may improve stability and expressibility in diverse cases, and that improvement typically requires target-specific expression conditions. This study demonstrates the strengths of community-wide efforts to probe the generality of new methods and recommends areas for future research to advance practically useful algorithms for protein science.
Charité University Medicine Charitéplatz 1 10117 Berlin Germany
Department of Biomolecular Sciences Weizmann Institute of Science Rehovot 7610001 Israel
Department of Life Sciences Core Facilities Weizmann Institute of Science Rehovot 7610001 Israel
Elettra Sincrotrone Trieste SS 14 km 163 5 in Area Science Park 34149 Basovizza Trieste Italy
German Center for Cardiovascular Research Partner Site Berlin Berlin Germany
Institut de Génétique et de Biologie Moléculaire et Cellulaire U1258 Université de Strasbourg France
Laboratory for Environmental and Life Sciences University of Nova Gorica Slovenia
Max Delbrück Center for Molecular Medicine Robert Rössle Straße 10 13125 Berlin Buch Germany
NORCE Norwegian Research Centre Postboks 22 Nygårdstangen 5038 Bergen Norway
The University of Queensland Institute for Molecular Bioscience St Lucia Queensland 4072 Australia
Unité Mixte de Recherche Marseille France
University of Lübeck Institute for Biology Ratzeburger Allee 160 23562 Lübeck Germany
Vienna Biocenter Core Facilities GmbH Dr Bohr gasse 3 1030 Vienna Austria
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21025528
- 003
- CZ-PrNML
- 005
- 20211026133730.0
- 007
- ta
- 008
- 211013s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jmb.2021.166964 $2 doi
- 035 __
- $a (PubMed)33781758
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Peleg, Yoav $u Department of Life Sciences Core Facilities (LSCF), Weizmann Institute of Science, Rehovot 7610001, Israel. Electronic address: yoav.peleg@weizmann.ac.il
- 245 10
- $a Community-Wide Experimental Evaluation of the PROSS Stability-Design Method / $c Y. Peleg, R. Vincentelli, BM. Collins, KE. Chen, EK. Livingstone, S. Weeratunga, N. Leneva, Q. Guo, K. Remans, K. Perez, GEK. Bjerga, Ø. Larsen, O. Vaněk, O. Skořepa, S. Jacquemin, A. Poterszman, S. Kjær, E. Christodoulou, S. Albeck, O. Dym, E. Ainbinder, T. Unger, A. Schuetz, S. Matthes, M. Bader, A. de Marco, P. Storici, MS. Semrau, P. Stolt-Bergner, C. Aigner, S. Suppmann, A. Goldenzweig, SJ. Fleishman
- 520 9_
- $a Recent years have seen a dramatic improvement in protein-design methodology. Nevertheless, most methods demand expert intervention, limiting their widespread adoption. By contrast, the PROSS algorithm for improving protein stability and heterologous expression levels has been successfully applied to a range of challenging enzymes and binding proteins. Here, we benchmark the application of PROSS as a stand-alone tool for protein scientists with no or limited experience in modeling. Twelve laboratories from the Protein Production and Purification Partnership in Europe (P4EU) challenged the PROSS algorithm with 14 unrelated protein targets without support from the PROSS developers. For each target, up to six designs were evaluated for expression levels and in some cases, for thermal stability and activity. In nine targets, designs exhibited increased heterologous expression levels either in prokaryotic and/or eukaryotic expression systems under experimental conditions that were tailored for each target protein. Furthermore, we observed increased thermal stability in nine of ten tested targets. In two prime examples, the human Stem Cell Factor (hSCF) and human Cadherin-Like Domain (CLD12) from the RET receptor, the wild type proteins were not expressible as soluble proteins in E. coli, yet the PROSS designs exhibited high expression levels in E. coli and HEK293 cells, respectively, and improved thermal stability. We conclude that PROSS may improve stability and expressibility in diverse cases, and that improvement typically requires target-specific expression conditions. This study demonstrates the strengths of community-wide efforts to probe the generality of new methods and recommends areas for future research to advance practically useful algorithms for protein science.
- 650 12
- $a algoritmy $7 D000465
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a Escherichia coli $x metabolismus $7 D004926
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 _2
- $a rychlé screeningové testy $7 D057166
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a molekulární modely $7 D008958
- 650 12
- $a stabilita proteinů $7 D055550
- 650 _2
- $a proteiny $x chemie $x metabolismus $7 D011506
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a teplota $7 D013696
- 650 _2
- $a dánio pruhované $7 D015027
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vincentelli, Renaud $u Unité Mixte de Recherche (UMR) 7257, Centre National de la Recherche Scientifique (CNRS) Aix-Marseille Université, Architecture et Fonction des Macromolécules Biologiques (AFMB), Marseille, France
- 700 1_
- $a Collins, Brett M $u The University of Queensland, Institute for Molecular Bioscience, St. Lucia, Queensland 4072, Australia
- 700 1_
- $a Chen, Kai-En $u The University of Queensland, Institute for Molecular Bioscience, St. Lucia, Queensland 4072, Australia
- 700 1_
- $a Livingstone, Emma K $u The University of Queensland, Institute for Molecular Bioscience, St. Lucia, Queensland 4072, Australia
- 700 1_
- $a Weeratunga, Saroja $u The University of Queensland, Institute for Molecular Bioscience, St. Lucia, Queensland 4072, Australia
- 700 1_
- $a Leneva, Natalya $u The University of Queensland, Institute for Molecular Bioscience, St. Lucia, Queensland 4072, Australia
- 700 1_
- $a Guo, Qian $u The University of Queensland, Institute for Molecular Bioscience, St. Lucia, Queensland 4072, Australia
- 700 1_
- $a Remans, Kim $u European Molecular Biology Laboratory (EMBL), Protein Expression and Purification Core Facility, Meyerhofstrasse 1, 69117 Heidelberg, Germany
- 700 1_
- $a Perez, Kathryn $u European Molecular Biology Laboratory (EMBL), Protein Expression and Purification Core Facility, Meyerhofstrasse 1, 69117 Heidelberg, Germany
- 700 1_
- $a Bjerga, Gro E K $u NORCE Norwegian Research Centre, Postboks 22 Nygårdstangen, 5038 Bergen, Norway
- 700 1_
- $a Larsen, Øivind $u NORCE Norwegian Research Centre, Postboks 22 Nygårdstangen, 5038 Bergen, Norway
- 700 1_
- $a Vaněk, Ondřej $u Department of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840 Prague, Czech Republic
- 700 1_
- $a Skořepa, Ondřej $u Department of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840 Prague, Czech Republic
- 700 1_
- $a Jacquemin, Sophie $u Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Centre National de la Recherche Scientifique (CNRS), UMR 7104, Institut National de la Santé et de la Recherche Médicale (INSERM), U1258, Université de Strasbourg, France
- 700 1_
- $a Poterszman, Arnaud $u Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Centre National de la Recherche Scientifique (CNRS), UMR 7104, Institut National de la Santé et de la Recherche Médicale (INSERM), U1258, Université de Strasbourg, France
- 700 1_
- $a Kjær, Svend $u Structural Biology Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
- 700 1_
- $a Christodoulou, Evangelos $u Structural Biology Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
- 700 1_
- $a Albeck, Shira $u Department of Life Sciences Core Facilities (LSCF), Weizmann Institute of Science, Rehovot 7610001, Israel
- 700 1_
- $a Dym, Orly $u Department of Life Sciences Core Facilities (LSCF), Weizmann Institute of Science, Rehovot 7610001, Israel
- 700 1_
- $a Ainbinder, Elena $u Department of Life Sciences Core Facilities (LSCF), Weizmann Institute of Science, Rehovot 7610001, Israel
- 700 1_
- $a Unger, Tamar $u Department of Life Sciences Core Facilities (LSCF), Weizmann Institute of Science, Rehovot 7610001, Israel
- 700 1_
- $a Schuetz, Anja $u Max-Delbrück Center for Molecular Medicine (MDC), Robert-Rössle-Straße 10, 13125 Berlin-Buch, Germany
- 700 1_
- $a Matthes, Susann $u Max-Delbrück Center for Molecular Medicine (MDC), Robert-Rössle-Straße 10, 13125 Berlin-Buch, Germany
- 700 1_
- $a Bader, Michael $u Max-Delbrück Center for Molecular Medicine (MDC), Robert-Rössle-Straße 10, 13125 Berlin-Buch, Germany; University of Lübeck, Institute for Biology, Ratzeburger Allee 160, 23562 Lübeck, Germany; Charité University Medicine, Charitéplatz 1, 10117 Berlin, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany
- 700 1_
- $a de Marco, Ario $u Laboratory for Environmental and Life Sciences, University of Nova Gorica, Slovenia
- 700 1_
- $a Storici, Paola $u Elettra Sincrotrone Trieste - SS 14 - km 163, 5 in Area Science Park, 34149 Basovizza, Trieste, Italy
- 700 1_
- $a Semrau, Marta S $u Elettra Sincrotrone Trieste - SS 14 - km 163, 5 in Area Science Park, 34149 Basovizza, Trieste, Italy
- 700 1_
- $a Stolt-Bergner, Peggy $u Vienna Biocenter Core Facilities GmbH, Dr. Bohr-gasse 3, 1030 Vienna, Austria
- 700 1_
- $a Aigner, Christian $u Vienna Biocenter Core Facilities GmbH, Dr. Bohr-gasse 3, 1030 Vienna, Austria
- 700 1_
- $a Suppmann, Sabine $u Max-Planck Institute of Biochemistry, Biochemistry Core Facility, Am Klopferspitz 18, 82152 Martinsried, Germany
- 700 1_
- $a Goldenzweig, Adi $u Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel
- 700 1_
- $a Fleishman, Sarel J $u Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel. Electronic address: sarel.fleishman@weizmann.ac.il
- 773 0_
- $w MED00002808 $t Journal of molecular biology $x 1089-8638 $g Roč. 433, č. 13 (2021), s. 166964
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33781758 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133736 $b ABA008
- 999 __
- $a ok $b bmc $g 1714541 $s 1146035
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 433 $c 13 $d 166964 $e 20210327 $i 1089-8638 $m Journal of Molecular Biology $n J Mol Biol $x MED00002808
- GRA __
- $a 815379 $p European Research Council $2 International
- GRA __
- $a FC001999 $p Cancer Research UK $2 United Kingdom
- GRA __
- $a FC001999 $p Medical Research Council $2 United Kingdom
- GRA __
- $p Wellcome Trust $2 United Kingdom
- LZP __
- $a Pubmed-20211013